HTGM(Delisted)
Htg Molecular Diagnostics·NASDAQ
--
--(--)
HTGM fundamentals
Htg Molecular Diagnostics (HTGM) released its earnings on Aug 8, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 8, 2017
EPS
Revenue
Revenue & Expenses
HTGM has released its 2023 Q1 earnings report, with revenue of 1.03M, reflecting a YoY change of -12.83%, and net profit of -5.05M, showing a YoY change of 22.20%. The Sankey diagram below clearly presents HTGM's revenue sources and cost distribution.
Key Indicators
Htg Molecular Diagnostics (HTGM) key financial stats and ratios, covering profitability, financial health, and leverage.
Htg Molecular Diagnostics (HTGM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Htg Molecular Diagnostics (HTGM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Htg Molecular Diagnostics (HTGM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Htg Molecular Diagnostics (HTGM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Htg Molecular Diagnostics (HTGM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
